How Much a 30-Day Supply of Trelegy Costs Without Insurance
For uninsured individuals, the retail price of Trelegy is a substantial financial consideration. The average cash price for a 30-day supply (one 60-blister inhaler) can range from approximately $832 to over $917, depending on the specific pharmacy. This high cost is primarily due to Trelegy being a brand-name medication with a patented, triple-combination formula, meaning no generic equivalent is available to drive down prices.
Fortunately, there are resources available to help reduce this burden, even without insurance. Prescription discount cards, such as those from SingleCare or GoodRx, can significantly lower the price. With a coupon, the cash price for a month's supply could drop to around $534 to $669 at certain pharmacies. Patients can compare prices online and present the discount card at their pharmacy to receive the reduced rate.
Understanding Your Trelegy Cost with Insurance
For those with health insurance, the out-of-pocket cost for Trelegy is much more manageable, though it still depends on the specific plan. Factors like your deductible, copay, and the insurance company's formulary (list of covered drugs) all play a role in the final price.
- Commercial Insurance: Eligible commercially insured patients can often pay as little as $0 per prescription. As of early 2025, the manufacturer GSK capped out-of-pocket costs at $35 per month for eligible commercially insured patients. Eligibility varies, so it is important to check the program details on the manufacturer's website. Prior to this, many commercially insured patients paid less than $50 monthly, but costs could rise depending on plan specifics.
- Medicare Part D: The cost for Medicare recipients can fluctuate throughout the calendar year as they move through different coverage phases. However, beginning in 2025, GSK implemented a $35 monthly cap for eligible Medicare patients. Some plans may require prior authorization to approve coverage. In general, a high percentage of Medicare patients previously paid less than $50 per month, with a smaller group paying more.
- Medicaid: For most Medicaid patients, the cost of Trelegy is a very low copay, typically ranging from $5 to $10 per month, though requirements can vary by state. Medicaid patients may also need prior authorization.
Programs to Reduce Your Trelegy Costs
Beyond insurance, several programs are designed to help patients afford Trelegy.
- Manufacturer Coupons and Copay Cards: For eligible commercially insured patients, the Trelegy Savings Program from GSK can reduce monthly costs to as low as $0 for up to 12 months. Patients can register online to receive a coupon card.
- Patient Assistance Program (PAP): GSK runs a Patient Assistance Program for low-income, uninsured patients or certain Medicare recipients. The program provides the medication at no cost for up to 12 months for eligible individuals. Enrollment involves completing an application and meeting specific income and insurance status criteria.
- Prescription Discount Cards: Services like SingleCare and GoodRx provide discount cards that can be used at participating pharmacies to get a lower price on the medication, especially for those without insurance or whose insurance doesn't cover the drug.
Factors that Influence the Price of Trelegy
The high cost of Trelegy is influenced by several key factors common to many brand-name pharmaceuticals.
- Triple-Combination Formula: Trelegy contains three active ingredients—fluticasone furoate, umeclidinium, and vilanterol—all in a single inhaler. Developing and manufacturing this triple combination is more complex and expensive than creating single-ingredient medications.
- Patent Protection: As a patented, brand-name drug, Trelegy faces no generic competition. This market exclusivity allows the manufacturer to set the price to recoup the significant investment in research, development, and clinical trials required for regulatory approval.
- Research and Development Costs: The pharmaceutical industry invests heavily in the research and development of new drugs. These costs are substantial, and the price of a successful drug must cover not only its own R&D but also the costs of failed drug candidates.
Comparison of Trelegy and Alternatives
For patients concerned about the cost, discussing alternatives with a healthcare provider is essential. Alternatives may not be suitable for everyone but offer potential cost savings. Here is a simplified comparison.
| Feature | Trelegy Ellipta | Breztri Aerosphere | Two-Inhaler Regimen (e.g., Breo + Incruse) |
|---|---|---|---|
| Active Ingredients | Triple-combination (ICS/LAMA/LABA) | Triple-combination (ICS/LAMA/LABA) | Combination of two separate inhalers |
| Administration | Once-daily, single inhaler | Twice-daily, single inhaler | Twice-daily or more, multiple inhalers |
| Average Cash Price (approx.) | $832–$917 per 30-day supply | ~$809 per 30-day supply | Varies by specific medications, potentially lower overall with generic options |
| Cost with Insurance | Varies; may be capped at $35 for many in 2025 | Varies; Boehringer Ingelheim also offers a $35 cap in 2024 for many of its inhalers | Varies; depends on formulary coverage for each inhaler |
| Convenience | Very high, single daily dose | High, single inhaler | Lower, requires managing multiple devices |
Conclusion
The question of "how much does a 30 day supply of Trelegy cost?" has a complex answer that depends heavily on an individual's insurance coverage and proactive efforts to find financial assistance. Without insurance, the retail price is very high, but discount cards offer a significant reduction. With commercial, Medicare, or Medicaid insurance, costs are much lower, with many patients now benefiting from a $35 monthly out-of-pocket cap implemented in 2025. For eligible low-income patients, manufacturer-sponsored patient assistance programs may provide the medication at no cost. Understanding the various factors and exploring all available savings options is crucial for anyone needing this medication for chronic respiratory conditions. Discussing these options with your healthcare provider and pharmacist can help ensure your treatment remains both effective and affordable.
Learn more about patient assistance programs on the GSK For You website: https://gskforyou.com/programs/patient-assistance-program/.
